Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort. Willis MD, Harding KE, Pickersgill TP, Wardle M, Pearson OR, Scolding NJ, Smee J, Robertson NP Mult Scler. 2015 Oct 29. PMID: 26514979. Abstract CommentRecommendBookmarkWatch